clinicaltrials:NCT00303667
Bio2RDF uri
clinicaltrials:NCT00303667
Bio2RDF identifier
NCT00303667
Bio2RDF namespace
clinicaltrials
Bio2RDF uri
http://bio2rdf.org/clinicaltrials:NCT00303667
identifiers.org URI
actual enrollment [clinicaltrials_vocabulary:actual-enrollment]
arm group [clinicaltrials_vocabulary:arm-group]
authority [clinicaltrials_vocabulary:authority]
baseline [clinicaltrials_vocabulary:baseline]
brief summary [clinicaltrials_vocabulary:brief-summary]
RATIONALE: Giving chemo ...... t for acute myeloid leukemia.
brief title [clinicaltrials_vocabulary:brief-title]
Donor Natural Killer Cells and ...... ing Donor Stem Cell Transplant
clinical result [clinicaltrials_vocabulary:clinical-result]
clinicaltrials_vocabulary:primary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:primary-outcome]
clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]
Disease-free Survival at 6 Months Month 6 [clinicaltrials_resource:0d6f692323670deaa1ba65821eddc570]
Disease-free Survival at 6 Months Month 6 [clinicaltrials_resource:2f8d60cece7bd838e773d92232e5bcc4]
Disease-free Survival at 6 Months Month 6 [clinicaltrials_resource:30cdff09070c92cb67957abd803f5cbd]
Disease-free Survival at 6 Months Month 6 [clinicaltrials_resource:3e09415ef1e2f86386200dcc8c2b7612]
Disease-free Survival at 6 Months Month 6 [clinicaltrials_resource:4370793612de067e807b388e3b1e4e1f]
completion date [clinicaltrials_vocabulary:completion-date]
2011-03-01T00:00:00Z
condition [clinicaltrials_vocabulary:condition]
condition browse [clinicaltrials_vocabulary:condition-browse]
condition mesh [clinicaltrials_vocabulary:condition-mesh]
country [clinicaltrials_vocabulary:country]
detailed description [clinicaltrials_vocabulary:detailed-description]
OBJECTIVES:
Prim ...... ll be accrued for this study.
download date [clinicaltrials_vocabulary:download-date]
ClinicalTrials.gov processed this data on August 10, 2015
eligibility [clinicaltrials_vocabulary:eligibility]
firstreceived date [clinicaltrials_vocabulary:firstreceived-date]
2006-03-15T00:00:00Z
firstreceived results date [clinicaltrials_vocabulary:firstreceived-results-date]
2015-06-11T00:00:00Z
has expanded access [clinicaltrials_vocabulary:has-expanded-access]
intervention [clinicaltrials_vocabulary:intervention]
intervention browse [clinicaltrials_vocabulary:intervention-browse]
is fda regulated [clinicaltrials_vocabulary:is-fda-regulated]
is section 801 [clinicaltrials_vocabulary:is-section-801]
keyword [clinicaltrials_vocabulary:keyword]
acute myelogenous leukemia
hematopoietic cell transplant
immunotherapy
natural killer cells
lastchanged date [clinicaltrials_vocabulary:lastchanged-date]
2015-06-11T00:00:00Z
lead sponsor [clinicaltrials_vocabulary:lead-sponsor]
link [clinicaltrials_vocabulary:link]
location [clinicaltrials_vocabulary:location]
nct id [clinicaltrials_vocabulary:nct-id]
NCT00303667
number of arms [clinicaltrials_vocabulary:number-of-arms]
official title [clinicaltrials_vocabulary:official-title]
Reduced Intensity Haploidentic ...... Myeloablative Transplantation
org study id [clinicaltrials_vocabulary:org-study-id]
outcome [clinicaltrials_vocabulary:outcome]
overall official [clinicaltrials_vocabulary:overall-official]
overall status [clinicaltrials_vocabulary:overall-status]
oversight [clinicaltrials_vocabulary:oversight]
participant flow [clinicaltrials_vocabulary:participant-flow]
phase [clinicaltrials_vocabulary:phase]
primary completion date [clinicaltrials_vocabulary:primary-completion-date]
2011-03-01T00:00:00Z
reported events [clinicaltrials_vocabulary:reported-events]
responsible party [clinicaltrials_vocabulary:responsible-party]
secondary id [clinicaltrials_vocabulary:secondary-id]
UMN-MT2003-23
source [clinicaltrials_vocabulary:source]
start date [clinicaltrials_vocabulary:start-date]
2005-01-01T00:00:00Z